These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 39396065)

  • 1. Development and characterization of novel anti-acetylated tau monoclonal antibodies to probe pathogenic tau species in Alzheimer's disease.
    Bryan Iii MR; Tian X; Tseng JH; Evangelista BA; Ragusa JV; Bryan AF; Trotman W; Irwin D; Cohen TJ
    Acta Neuropathol Commun; 2024 Oct; 12(1):163. PubMed ID: 39396065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acetylation of tau inhibits its function and promotes pathological tau aggregation.
    Cohen TJ; Guo JL; Hurtado DE; Kwong LK; Mills IP; Trojanowski JQ; Lee VM
    Nat Commun; 2011; 2():252. PubMed ID: 21427723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of retinoblastoma binding protein 7 (Rbbp7) as a mediator against tau acetylation and subsequent neuronal loss in Alzheimer's disease and related tauopathies.
    Dave N; Vural AS; Piras IS; Winslow W; Surendra L; Winstone JK; Beach TG; Huentelman MJ; Velazquez R
    Acta Neuropathol; 2021 Aug; 142(2):279-294. PubMed ID: 33978814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argyrophilic grain disease differs from other tauopathies by lacking tau acetylation.
    Grinberg LT; Wang X; Wang C; Sohn PD; Theofilas P; Sidhu M; Arevalo JB; Heinsen H; Huang EJ; Rosen H; Miller BL; Gan L; Seeley WW
    Acta Neuropathol; 2013 Apr; 125(4):581-93. PubMed ID: 23371364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
    Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
    Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauopathy: A common mechanism for neurodegeneration and brain aging.
    Saha P; Sen N
    Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.
    Xia Y; Prokop S; Gorion KM; Kim JD; Sorrentino ZA; Bell BM; Manaois AN; Chakrabarty P; Davies P; Giasson BI
    Acta Neuropathol Commun; 2020 Jun; 8(1):88. PubMed ID: 32571418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
    Parra Bravo C; Krukowski K; Barker S; Wang C; Li Y; Fan L; Vázquez-Rosa E; Shin MK; Wong MY; McCullough LD; Kitagawa RS; Choi HA; Cacace A; Sinha SC; Pieper AA; Rosi S; Chen X; Gan L
    Mol Neurodegener; 2024 Jun; 19(1):51. PubMed ID: 38915105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of new monoclonal antibodies targeting the PHF1 and AT8 epitopes on human tau.
    Strang KH; Goodwin MS; Riffe C; Moore BD; Chakrabarty P; Levites Y; Golde TE; Giasson BI
    Acta Neuropathol Commun; 2017 Jul; 5(1):58. PubMed ID: 28760159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau acetylation at K280 regulates tau phosphorylation.
    Kim MS; Mun YS; Lee SE; Cho WY; Han SH; Kim DH; Yoon SY
    Int J Neurosci; 2023 Dec; 133(12):1394-1398. PubMed ID: 35603448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody Y01 prevents tauopathy progression induced by lysine 280-acetylated tau in cell and mouse models.
    Song HL; Kim NY; Park J; Kim MI; Jeon YN; Lee SJ; Cho K; Shim YL; Lee KH; Mun YS; Song JA; Kim MS; Pack CG; Jung M; Jang H; Na DL; Hong M; Kim DH; Yoon SY
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36917188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.
    Roberts M; Sevastou I; Imaizumi Y; Mistry K; Talma S; Dey M; Gartlon J; Ochiai H; Zhou Z; Akasofu S; Tokuhara N; Ogo M; Aoyama M; Aoyagi H; Strand K; Sajedi E; Agarwala KL; Spidel J; Albone E; Horie K; Staddon JM; de Silva R
    Acta Neuropathol Commun; 2020 Feb; 8(1):13. PubMed ID: 32019610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HDAC6-dependent surveillance mechanism suppresses tau-mediated neurodegeneration and cognitive decline.
    Trzeciakiewicz H; Ajit D; Tseng JH; Chen Y; Ajit A; Tabassum Z; Lobrovich R; Peterson C; Riddick NV; Itano MS; Tripathy A; Moy SS; Lee VMY; Trojanowski JQ; Irwin DJ; Cohen TJ
    Nat Commun; 2020 Nov; 11(1):5522. PubMed ID: 33139698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation.
    Acosta DM; Mancinelli C; Bracken C; Eliezer D
    J Biol Chem; 2022 Jan; 298(1):101442. PubMed ID: 34838590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylated tau neuropathology in sporadic and hereditary tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; McCarty-Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ
    Am J Pathol; 2013 Aug; 183(2):344-51. PubMed ID: 23885714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.